Skip to main content
Go to the home page of the European Commission (opens in new window)
English English
CORDIS - EU research results
CORDIS

Leverage research EXCELLence and INNOVation potential of Instituto de Medicina Molecular (IMM) through translational biomedical research in immunity and infection.

Project description

Improving translational research capacity in Portugal

The Institute of Molecular Medicine (IMM) in Lisbon, Portugal is a biomedical research institute that promotes basic, clinical and translational research in the life sciences field. The EU-funded EXCELLtoINNOV project aims to enhance IMM's excellence in immunity and infection research through the recruitment of an ERA Chair. This will establish a research hub in Lisbon, positioning IMM at the forefront in this field. The strategy involves improvement in staffing and research infrastructure, expanding IMM’s research potential, supporting the formation of innovation clusters with the private sector and improving its international visibility. These efforts will enhance IMM’s competitiveness for research funding and establish new global collaborations.

Objective

EXCELLtoINNOV will provide IMM with the needed means to achieve excellence on a sustainable basis through the recruitment of an ERA Chair in translational biomedical research in immunity and infection. This goal will be strategically achieved by placing IMM in the forefront of Research, Development and Innovation (R&D+I) in immunity and infection, through the establishment of a translational biomedical research hub anchored in Lisbon that will: i. leverage the national potential beyond borders; ii. act as the interface of Europe with America and Africa; iii. and effectively contribute to overcome the health and demographic change societal challenges by potentiating major scientific advancements in this research area through worldwide collaborative efforts. The successful implementation of this strategy will be possible through specific activities, including: 1) the development of a new research field at IMM by the ERA Chair holder, pre-clinical molecular and imaging studies, that will transversally benefit and impact all research areas at IMM; 2) the implementation of structural changes at IMM to successfully support and comply with ERA priorities; 3) the expansion of overseas collaborations in international collaborative R&D+I projects; and 4) an improved integration of IMM in the regional, national and international business community. Through the completion of these activities we will achieve an improved capability to compete successfully for internationally competitive research funding, including but not limited to Horizon 2020, IMI2 and EDCTP2 as well as effectively contribute to the objectives of regional smart specialisation strategies through increased international attractiveness, competitiveness and innovation potential of IMM, Lisbon and Portugal.

Keywords

Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)

Programme(s)

Multi-annual funding programmes that define the EU’s priorities for research and innovation.

Topic(s)

Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.

Funding Scheme

Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.

CSA - Coordination and support action

See all projects funded under this funding scheme

Call for proposal

Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.

(opens in new window) H2020-WIDESPREAD-2014-2015

See all projects funded under this call

Coordinator

FUNDACAO GIMM - GULBENKIAN INSTITUTE FOR MOLECULAR MEDICINE
Net EU contribution

Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.

€ 2 499 465,00
Address
AVENIDA PROFESSOR EGAS MONIZ
1649-035 LISBOA
Portugal

See on map

Activity type
Research Organisations
Links
Total cost

The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.

€ 2 777 183,75
My booklet 0 0